21th december 2010 - Press release
Triple-negative breast cancer (Estrogen Receptor-Negative, Progesterone Receptor-Negative, and HER-Negative) is a type of breast cancer with clinical characteristics and specific pathologies that represents a relevant clinic problem, as it affects around 20% of all women with breast cancer, and especially those who are young.
15/09/2010 - Press release
A study carried out by researchers from the stem cells and cancer research group of the IMIM (Hospital del Mar Research Institute) has shown that if deactivation of the NFkB protein complex in T cell acute lymphoblastic leukaemia is forced, leukaemia is eliminated. This opens the doors for the development of new drugs for this type of leukaemia.
Més informació "New therapeutic avenue discovered to fight against leukaemia"
10 august 2010 - Press release
This is the first study in which proteins involved in metabolism and muscle contraction are shown to have higher levels of oxidation as a result of tobacco smoke, which could cause alterations in the structure and function of muscle fibres.
Més informació "Cigarette smoke contributes to muscle dysfunction"
14/07/2009 - Press release
Experts of the IMIM-Hospital del Mar Cancer Research Programme have collaborated on a study that identifies new keys in breast cancer tumour invasion. The study has been published in the prestigious journal Nature Cell Biology.
Més informació "Keys to reprogramming cells and suppressing tumour invasion"
07/07/2009 - General information
Following the assessment by the National Agency of Evaluation and Prospective Studies (ANEP), the Foundation Board of the Spanish Association Against Cancer (AECC) approved, on 17 June, the awarding of two grants worth 1,200,000 euros over a period of 5 years to research programmes that jointly coordinate and run a translational research programme.
Més informació "The AECC grants €1,200,000 to a project in which IMIM is participating"
02/04/2009 - Press release
A study has identified a new molecular mechanism connected with the proliferation and invasion of tumour cells in pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer (90% of all cases). Pancreatic cancer is one of the most lethal tumours and the fourth leading cause of cancer death worldwide.
5ht February 2009 - Press release
Although physical exercise has beneficial effects for all, even those diagnosed with Chronic Obstructive Pulmonary Disease (COPD), a new study warns that levels of oxidative stress much higher than those at rest conditions may occur in the leg muscles of patients with severe and very severe COPD. The study was carried out in collaboration with Dr. Esther Barreiro’s group at the Municipal Institute of Medical Research (IMIM-Hospital del Mar), together with Dr. Joaquim Gea, head of the Pneumology service at the Hospital del Mar and with Dr. Josep Roca, Director of the Lung Function Unit at the Hospital Clínic-IDIBAPS.
Més informació "A study questions chronic endurance exercise in patients with severe COPD"
08/10/2008 - Press release
A study directed by Anouchka Skoudy in which researchers from IMIM and UPF took part, in collaboration with other European institutions, has enabled the generation of pancreatic cells with acinar phenotypes under controlled conditions for the first time.
08/10/2008 - General information
The European Respiratory Society (ERS) rewarded this year Esther Barreiro with the Society's annual award for research in the field of Chronic Obstructive Pulmonary Disease (COPD) 2008, for her study of the role of oxidative stress in the respiratory and peripheral muscle dysfunction of COPD patients.
Més informació "The ERS rewards Esther Barreiro for her research in the field of COPD"
07/04/06 - Institutional news
The registration to participate in the workshop “Programming Pancreatic ß-cells” is open until 1 August 2006. This event will be held from 18 to 22th October at El Perelló (in the Delta de l’Ebre).
Més informació "Registration is open for the workshop: “Programming Pancreatic ß-cells""
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact